» Articles » PMID: 34717565

Norovirus GII.2[P16] Strain in Shenzhen, China: a Retrospective Study

Overview
Journal BMC Infect Dis
Publisher Biomed Central
Date 2021 Oct 31
PMID 34717565
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Norovirus (NoV) is the main cause of non-bacterial acute gastroenteritis (AGE) outbreaks worldwide. From September 2015 through August 2018, 203 NoV outbreaks involving 2500 cases were reported to the Shenzhen Center for Disease Control and Prevention.

Methods: Faecal specimens for 203 outbreaks were collected and epidemiological data were obtained through the AGE outbreak surveillance system in Shenzhen. Genotypes were determined by sequencing analysis. To gain a better understanding of the evolutionary characteristics of NoV in Shenzhen, molecular evolution and mutations were evaluated based on time-scale evolutionary phylogeny and amino acid mutations.

Results: A total of nine districts reported NoV outbreaks and the reported NoV outbreaks peaked from November to March. Among the 203 NoV outbreaks, 150 were sequenced successfully. Most of these outbreaks were associated with the NoV GII.2[P16] strain (45.3%, 92/203) and occurred in school settings (91.6%, 186/203). The evolutionary rates of the RdRp region and the VP1 sequence were 2.1 × 10 (95% HPD interval, 1.7 × 10-2.5 × 10) substitutions/site/year and 2.7 × 10 (95% HPD interval, 2.4 × 10-3.1 × 10) substitutions/site/year, respectively. The common ancestors of the GII.2[P16] strain from Shenzhen and GII.4 Sydney 2012[P16] diverged from 2011 to 2012. The common ancestors of the GII.2[P16] strain from Shenzhen and previous GII.2[P16] (2010-2012) diverged from 2003 to 2004. The results of amino acid mutations showed 6 amino acid substitutions (*77E, R750K, P845Q, H1310Y, K1546Q, T1549A) were found only in GII.4 Sydney 2012[P16] and the GII.2[P16] recombinant strain.

Conclusions: This study illustrates the molecular epidemiological patterns in Shenzhen, China, from September 2015 to August 2018 and provides evidence that the epidemic trend of GII.2[P16] recombinant strain had weakened and the non-structural proteins of the recombinant strain might have played a more significant role than VP1.

Citing Articles

Biological and immunological characterization of major capsid protein VP1 from distinct GII.2 norovirus clusters.

Ma J, Liu J, Huo Y Sci Rep. 2024; 14(1):21035.

PMID: 39251865 PMC: 11385941. DOI: 10.1038/s41598-024-72062-2.


Changing predominance of norovirus strains in children with acute gastroenteritis in Shanghai, 2018-2021.

Lu L, Ao Y, Jia R, Zhong H, Liu P, Xu M Virol Sin. 2023; 38(5):671-679.

PMID: 37619918 PMC: 10590699. DOI: 10.1016/j.virs.2023.08.005.

References
1.
Lindesmith L, Beltramello M, Donaldson E, Corti D, Swanstrom J, Debbink K . Immunogenetic mechanisms driving norovirus GII.4 antigenic variation. PLoS Pathog. 2012; 8(5):e1002705. PMC: 3355092. DOI: 10.1371/journal.ppat.1002705. View

2.
Bull R, Tanaka M, White P . Norovirus recombination. J Gen Virol. 2007; 88(Pt 12):3347-3359. DOI: 10.1099/vir.0.83321-0. View

3.
Hardy M, Estes M . Completion of the Norwalk virus genome sequence. Virus Genes. 1996; 12(3):287-90. DOI: 10.1007/BF00284649. View

4.
Han J, Wu X, Chen L, Fu Y, Xu D, Zhang P . Emergence of norovirus GII.P16-GII.2 strains in patients with acute gastroenteritis in Huzhou, China, 2016-2017. BMC Infect Dis. 2018; 18(1):342. PMC: 6056945. DOI: 10.1186/s12879-018-3259-6. View

5.
Deval J, Jin Z, Chuang Y, Kao C . Structure(s), function(s), and inhibition of the RNA-dependent RNA polymerase of noroviruses. Virus Res. 2017; 234:21-33. PMC: 7114559. DOI: 10.1016/j.virusres.2016.12.018. View